SMTL ID : 2xfh.1

Structure of cytochrome P450 EryK cocrystallized with inhibitor clotrimazole.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 25 residues within 4Å: Chain A: I.87, H.88, H.95, R.99, F.106, F.234, L.238, A.241, T.245, L.249, L.282, P.287, F.288, M.291, R.293, S.345, F.346, G.347, V.350, H.351, C.353, L.354, G.355, A.359 Ligands: CL6.2 24 PLIP interactions: 24 interactions with chain A, Hydrophobic interactions: A:I.87, A:H.88, A:F.106, A:F.234, A:L.238, A:A.241, A:T.245, A:L.249, A:L.282, A:P.287, A:F.288, A:F.346, A:L.354, A:A.359 Water bridges: A:S.71, A:H.88, A:Q.292 Salt bridges: A:H.95, A:R.99, A:R.293, A:H.351, A:H.351 pi-Stacking: A:F.346 Metal complexes: A:C.353

2 x CL6: 1-[(2-CHLOROPHENYL)(DIPHENYL)METHYL]-1H-IMIDAZOLE(Non-covalent)

CL6.2: 9 residues within 4Å: Chain A: H.88, Q.173, A.237, L.240, A.241, T.245, F.288 Ligands: HEM.1, CL6.3 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.237, A:F.288 pi-Stacking: A:F.288 Halogen bonds: A:A.237 CL6.3: 9 residues within 4Å: Chain A: H.88, L.169, Q.173, I.186, L.190, T.236, A.237, L.240 Ligands: CL6.2 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.169, A:L.169, A:Q.173, A:I.186, A:I.186, A:T.236, A:L.240 Halogen bonds: A:Q.173

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.4: 4 residues within 4Å: Chain A: P.92, H.95, R.96, V.350 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Montemiglio, L.C. et al., Azole Drugs Trap Cytochrome P450 Eryk in Alternative Conformational States. Biochemistry (2010)

Release Date

2010-09-29

Peptides

ERYTHROMYCIN B/D C-12 HYDROXYLASE: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ERYTHROMYCIN B/D C-12 HYDROXYLASE

Related Entries With Identical Sequence